Ian Paterson pitched cleavage-sparing mastectomy ‘like sales job’, inquest told

Procedures performed by convicted breast surgeon were not a recognised or authorised type of operation

The convicted breast surgeon Ian Paterson pitched one of his patients an unauthorised cleavage-sparing mastectomy “almost like a sales job”, an inquest has heard.

Chloe Nikitas, an environmental consultant from Tamworth, died in 2008 at the age of 43 from breast cancer that returned three years after having a mastectomy she believed had removed all of her breast tissue.

Continue reading...

Elle Macpherson refused chemotherapy after secret breast cancer diagnosis

Supermodel says she is in remission after being diagnosed seven years ago and rejecting traditional medicine

Elle Macpherson has said she was diagnosed with breast cancer seven years ago but is now in remission despite refusing chemotherapy.

The Australian supermodel and actor, who rose to fame in the 1980s, is publishing a memoir – Elle: Life, Lessons, and Learning to Trust Yourself – in which she says she took a holistic approach to the illness, going against the advice of 32 doctors.

Continue reading...

Women in England and Wales denied ‘exciting’ drug that can stop breast cancer spreading

Latest study shows Enhertu, rejected by Nice, can stall growth of tumours by a year, longer than standard chemotherapy

Thousands of women with advanced breast cancer in England and Wales are being denied a drug that cuts the risk of the disease spreading by more than a third.

Enhertu has been rolled out to patients with HER2-low breast cancer in Scotland and Northern Ireland, but the National Institute for Health and Care Excellence (Nice) has rejected it for patients in England. Women in Wales are also being denied the drug.

Continue reading...

Predictive blood test hailed as ‘incredibly exciting’ breast cancer breakthrough

New ‘liquid biopsy’ will act as an early warning sign to anticipate risk of tumours returning

A new blood test can predict the risk of breast cancer returning three years before any tumours show up on scans in an “incredibly exciting” breakthrough that could help more women beat the disease for good.

More than 2 million women are diagnosed every year with breast cancer, the most prevalent type of the disease. Although treatment has improved in recent decades, the cancer often returns, and if it does, it is usually at a more advanced stage.

Continue reading...

Scientists make potential breast cancer breakthrough after preserving tissue in gel

Ability to preserve tissue in a special gel solution for at least a week will help doctors identify most effective drug treatments

Scientists say they have a made a potentially “gamechanging” breakthrough in breast cancer research after discovering how to preserve breast tissue outside the body for at least a week.

The study, which was funded by the Prevent Breast Cancer charity, found tissue could be preserved in a special gel solution, which will help scientists identify the most effective drug treatments for patients.

Continue reading...

Lower-income US women more likely to miss key breast cancer test, study finds

Isolation and lack of health insurance also correlate to reduced mammogram rates for breast cancer

Women who are low-income, socially isolated and lack health insurance are far less likely to be up-to-date on mammograms, a breast cancer screening tool experts said is critical to reducing breast cancer deaths, according to a new report from the Centers for Disease Control and Prevention (CDC).

Breast cancer is one of the most common types of cancer to afflict American women, and kills an estimated 40,000 Americans each year. Cancer overall kills 605,000 Americans a year and is the second-leading cause of death, a toll the Biden administration aims to reduce through a Cancer Moonshot initiative.

Continue reading...

UK scientists working on breast cancer monitor fitted in bra

Researchers at Nottingham Trent University hope device used at home will improve tracking of tumours

Scientists are developing a device that fits inside a bra and could monitor whether a breast cancer tumour is growing.

Researchers hope the device will provide a new non-invasive method of detecting tumour growth that patients can use “in the comfort of their own homes”.

Continue reading...

Labour MP Foy says she has breast cancer and urges others to get checked

Mary Kelly Foy, the MP for Durham, is recuperating from surgery and is expected to make a full recovery

A Labour MP has urged women to attend breast cancer screenings as she revealed her own diagnosis.

Mary Kelly Foy, the City of Durham MP, said she was recuperating from surgery and was expected to make a full recovery thanks to an early diagnosis.

Continue reading...

Late MP Peta Murphy remembered as ‘brave and loved’ by Anthony Albanese in emotional tribute

‘It was so true to Peta’s character that she channelled her personal battle with breast cancer into public policy’, PM says

Anthony Albanese has confirmed that Labor MP Peta Murphy, 50, has died from breast cancer. The prime minister struggled to hold back tears as he confirmed Murphy’s passing in a short statement from parliament house on Monday afternoon.

Murphy, the member for Dunkley, attended the final sitting week of the House of Representatives last week before returning home for palliative care. The MP died at home in the company of her parents and siblings and her husband of more than two decades, Rod Glover.

Sign up for Guardian Australia’s free morning and afternoon email newsletters for your daily news roundup

Continue reading...

Drug that can halve breast cancer risk offered to 289,000 women in England

Anastrozole to be made available to women who have been through the menopause and have family history of breast cancer

Almost 300,000 women at higher risk of developing breast cancer are being given access to a drug that can halve their risk in a “major step forward” in the fight against the disease.

An estimated 289,000 women in England who are at moderate or high risk of breast cancer will from Tuesday be able to take the tablet to try to prevent it from developing, NHS bosses said.

Continue reading...

‘Million megawatt smile’: Friends pay tribute to Victorian MP Jane Garrett at state memorial service

Former Labor minister celebrated as one of the state’s ‘most respected daughters’

Victorian Labor MP Jane Garrett has been remembered as a courageous and principled politician and a doting mother of three during a memorial service in Melbourne.

Family, friends and state and federal parliamentarians from across the political divide gathered at a state memorial at the Brunswick town hall – in the MP’s former electorate – on Friday morning to pay tribute to Garrett.

Sign up to receive an email with the top stories from Guardian Australia every morning

Continue reading...

Jane Garrett, Victorian Labor MP, dies from breast cancer aged 49

Former emergency services minister offered a state funeral to honour her ‘life of service’

The family of Victorian Labor MP Jane Garrett has has accepted the offer of a state funeral to farewell the former emergency services minister who has died from breast cancer at the age of 49.

The Victorian premier, Daniel Andrews, said the service would be “a fitting way to mark her significant contribution” to the state.

Continue reading...

NHS to offer women in England drug that cuts recurrence of breast cancer

Abemaciclib can improve chances of certain type of cancer not returning after surgery by more than 30%

Thousands of women in England with breast cancer are to benefit from a new pill on the NHS which reduces the risk of the disease coming back.

The National Institute for Health and Care Excellence (Nice) has given the green light to abemaciclib, which cuts the chance of breast cancer returning after a patient has had surgery to remove a tumour.

Continue reading...

‘Overdiagnosis’: some breast cancer treatments may have been unnecessary, study suggests

Exclusive: Patients tell of screening and surgery they believe they didn’t need, and the effect this has had on their lives

When Jenny* had a mastectomy after being diagnosed with breast cancer, she believed the major surgery to remove her breast, although traumatic, had saved her life.

She described feeling “rage” when at a follow-up appointment three years later, she said to her surgeon, “I would probably be dead by now” if she had not received the surgery, to which he replied: “Probably not.”

Sign up to receive an email with the top stories from Guardian Australia every morning

Continue reading...

Women in England with breast cancer may qualify for drug that buys ‘precious’ time

Nice approves Keytruda, which with chemotherapy can lengthen survival of women with triple negative breast cancer

Women with advanced breast cancer in England will be able to benefit from a new type of immunotherapy on the NHS after a U-turn by the medicines watchdog.

The National Institute for Health and Care Excellence (Nice) has overturned its draft rejection of Keytruda (pembrolizumab) and said women in England can take the drug in combination with chemotherapy.

Continue reading...

Scientists developing single test to detect risk of four cancers in women

Experts may be able to predict risk of developing ovarian, breast, womb and cervical cancers using cells from routine smear test

Scientists are developing a “revolutionary” test to predict a woman’s risk of four cancers using a single sample collected during cervical screening.

Using cervical cells from a routine smear test, experts may be able to spot ovarian and breast cancer or predict their likelihood of developing, according to two papers published in the journal Nature Communications. Further results are due on the ability of the WID-test – women’s cancer risk identification – to predict womb and cervical cancer, researchers said.

Continue reading...

‘Highly effective’ ovarian cancer treatment could help thousands of women

New drug combination shrunk tumours significantly in 46% of patients with treatment-resistant form of disease

Thousands of women with ovarian cancer could benefit from a revolutionary drug combination after it was shown to shrink tumours in half of patients with an advanced form of the disease.

The pair of drugs – which work together to block the signals cancer cells need to grow – could offer a new treatment option for women with a type of ovarian cancer that rarely responds to chemotherapy or hormone therapy.

Continue reading...

Alcohol linked to more cancers than thought, study finds

Imperial College London researchers also find that drinking coffee protects against liver cancer

Consuming alcohol increases the risk of getting more cancers than previously thought, according to a major study, which also found that drinking coffee protects against liver cancer.

Alcohol consumption is linked to several cancers including those of the head and neck – mouth, pharynx and larynx – oesophageal and bowel, along with the more widely known connection with breast and liver cancer, according to an international team led by Imperial College London.

Continue reading...

Alcohol caused 740,000 cancer cases globally last year – study

Researchers behind estimate say more needs to be done to raise public awareness of link

Alcohol is estimated to have caused more than 740,000 cancer cases around the world last year, and experts say more needs to be done to highlight the link.

There is strong evidence that alcohol consumption can cause various cancers including those of the breast, liver, colon, rectum, oropharynx, larynx and oesophagus. Research suggests that even low levels of drinking can increase the risk.

Continue reading...

How race to track mystery gene with links to three cancers saved millions

25 years ago, a mutation was discovered that makes some people susceptible to the disease, and now it has transformed treatment

Ten years ago, Tony Herbert developed a lump on the right side of his chest. The clump of tissue grew and became painful and he was tested for breast cancer. The result was positive.

“I had surgery and chemotherapy and that worked,” he said last week. But how had Herbert managed to develop a condition that is so rare in men? Only about 400 cases of male breast cancer are diagnosed every year in the UK compared with around 55,000 in women. A genetic test revealed the answer. Herbert had inherited a pathogenic version of a gene called BRCA2 and this mutation had triggered his condition.

Continue reading...